BRCA1 promoter hypermethylation on circulating tumor DNA correlates with improved survival of patients with ovarian cancer-Reference-Cited by-同舟云学术

BRCA1 promoter hypermethylation on circulating tumor DNA correlates with improved survival of patients with ovarian cancer

Published:2021-10-12 Issue:12 Volume:15 Page:3615-3625
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Mol Oncol

Author:

Elazezy Maha¹^ORCID,Prieske Katharina²³,Kluwe Lan⁴,Oliveira‐Ferrer Leticia²^ORCID,Peine Sven⁵,Müller Volkmar²,Woelber Linn²,Schmalfeldt Barbara²,Pantel Klaus¹,Joosse Simon A.¹³^ORCID

Affiliation:

1. Department of Tumor Biology University Medical Center Hamburg‐Eppendorf Hamburg Germany

2. Department of Gynecology and Gynecologic Oncology University Medical Center Hamburg‐Eppendorf Hamburg Germany

3. Mildred Scheel Cancer Career Center HaTriCS4 University Medical Center Hamburg‐Eppendorf Hamburg Germany

4. Department of Oral and Maxillofacial Surgery University Medical Center Hamburg‐Eppendorf Hamburg Germany

5. Department of Transfusion Medicine University Medical Center Hamburg‐Eppendorf Hamburg Germany

Funder

Universität Hamburg

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1878-0261.13108

Reference34 articles.

1. Integrated genomic analyses of ovarian carcinoma

2. Germline and Somatic Mutations in Homologous Recombination Genes Predict Platinum Response and Survival in Ovarian, Fallopian Tube, and Peritoneal Carcinomas

3. Deleterious somatic variants in 473 consecutive individuals with ovarian cancer: results of the observational AGO-TR1 study (NCT02222883)

4. Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1)

5. Promoter Hypermethylation and BRCA1 Inactivation in Sporadic Breast and Ovarian Tumors

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Global research trends in liquid biopsy for ovarian cancer from 1999 to 2023: A 25-year bibliometric analysis;The Journal of Liquid Biopsy;2024-09

2. Circulating tumor DNA as a biomarker for predicting progression-free survival and overall survival in patients with epithelial ovarian cancer: a systematic review and meta-analysis;International Journal of Gynecologic Cancer;2024-04-23

3. Current Applications and Challenges of Next-Generation Sequencing in Plasma Circulating Tumour DNA of Ovarian Cancer;Biology;2024-01-31

4. The role of aberrant DNA methylation in cancer initiation and clinical impacts;Therapeutic Advances in Medical Oncology;2024-01

5. Ovarian Cancer Diagnosis and Prognosis Based on Cell-Free DNA Methylation;Cancer Control;2024-01